Company Profile
Integra LifeSciences Stock Price, News & Analysis
- Ticker:
- IART
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
17.10 USD (-3.28%)
Close
Last updated: August 6, 2026
1.22B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IART closed down 3.28% at $17.10. No new same-company headline was identified in the current news window.
Company overview
Medical Technology Portfolio
Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes.
Neurosurgical Technologies
The company supplies instruments, implants and systems used in neurosurgery and neurocritical care. These products include technologies for dural repair, intracranial pressure management, tissue ablation and precision surgical access.
Tissue and Wound Reconstruction
Integra’s regenerative-tissue portfolio includes products used for soft-tissue reinforcement, wound closure and surgical reconstruction. SurgiMend is a biologic matrix intended to return to production from the company’s Braintree manufacturing facility.
Future catalysts
Start of SurgiMend production at the Braintree facility targeted by the end of June 2026.
Relaunch of SurgiMend expected in the fourth quarter of 2026.
Recent news
- 01
Integra LifeSciences Reports Second Quarter 2026 Financial Results
Source: Integra LifeSciences
- 02
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
Source: Integra LifeSciences
- 03
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Source: Integra LifeSciences
- 04
Integra LifeSciences Announces Key Executive Appointments
Source: Integra LifeSciences
- 05
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Source: Integra LifeSciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Integra LifeSciences (IART)?
Integra LifeSciences (IART) most recently closed at 17.10 USD, a -3.28% move versus the previous session.
What is the market cap of Integra LifeSciences (IART)?
Integra LifeSciences currently has a market capitalization of 1.22B USD on BioPharmSignal.
What does Integra LifeSciences do?
Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and systems used in...
On which exchange is IART stock listed?
Integra LifeSciences (IART) is associated with NASDAQ, United States, Biopharma.
What is Medical?
Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care.
Which conditions is Integra LifeSciences targeting with Medical?
Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and systems used in...
How does Integra LifeSciences describe recent progress with Medical?
Start of SurgiMend production at the Braintree facility targeted by the end of June 2026. Relaunch of SurgiMend expected in the fourth quarter of 2026.
What is Technology?
Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care.